BRKR

Bruker Corporation

67.99 USD

Last updated Dec 11, 09:14 UTC

Yesterday HIGH

$69.72

Yesterday LOW

$67.78

52w HIGH

$84.84

52w LOW

$53.79

EPS

0.74

PE

91.88

Next Earnings

Feb 8, 2024

Overview News Insider Transactions Government Trades

Bruker Corporation stock is up 17.61% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.38% of the previous 20 December’s closed higher than November.

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Measuring And Control Equipment

Headquarters

Billerica, United States Of America

Website

bruker.com

Benzinga Newsdesk

Mon May 8, 2023

Bruker Acquires ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions; Terms Undisclosed

Bruker Corporation (NASDAQ:BRKR) today announced that is has closed the acquisition of ZONTAL Inc. (www.zontal.io), an innovative platform provider for the digital transformation of the analytical laboratory,
sunil@benzinga.com

Fri May 5, 2023

Citigroup Maintains Buy on Bruker, Raises Price Target to $95

Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $90 to $95.
Benzinga Newsdesk

Thu May 4, 2023

Bruker Corp Boosts FY23 Revenue To $2.83B-$2.88B, Up From $2.81B-$2.86B (Consensus $2.82B), Adj EPS To $2.55-$2.60, Up From $2.52-$2.57 (Consensus $2.56)
Benzinga Insights

Thu May 4, 2023

Recap: Bruker Q1 Earnings
Benzinga Newsdesk

Thu May 4, 2023

Bruker Q1 Adj EPS $0.64 Beats $0.55 Estimate, Sales $685.30M Beat $639.75M Estimate

Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.55 by 16.36 percent. This is a 30.61 percent increase over earnings of $0.49 per share from the same
Benzinga Insights

Thu May 4, 2023

Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
Benzinga Insights

Wed May 3, 2023

Bruker's Earnings: A Preview
Benzinga Newsdesk

Wed Apr 19, 2023

Goldman Sachs Maintains Sell on Bruker, Raises Price Target to $70

Goldman Sachs analyst Matthew Sykes maintains Bruker (NASDAQ:BRKR) with a Sell and raises the price target from $63 to $70.
Benzinga Newsdesk

Tue Apr 18, 2023

Goldman Sachs Maintains Sell on Bruker, Raises Price Target to $70

Goldman Sachs maintains Bruker (NASDAQ:BRKR) with a Sell and raises the price target from $63 to $70.
Benzinga Newsdesk

Wed Apr 12, 2023

Canopy Biosciences, A Bruker Corporation Company, And Enable Medicine, Announced A Partnership To Provide Enable Medicine's Advanced Analysis Pipelines For Spatial Omics Data With The Canopy Cellscape System For Quantitative High-Plex Spatial Biology

The Canopy CellScape system allows for quantitative, high-plex spatial proteomics imaging with leading quantitative performance. Enable Medicine's Enable Cloud platform accelerates biological insights via advanced